Similar articles

• Non-stimulant trials of adult ADHD.

  Adler LA. Adler LA. CNS Spectr. 2007 Apr;12(4 Suppl 6):11-3. doi: 10.1017/s109285290002602x. CNS Spectr. 2007. PMID: 17717871 Review. No abstract available.
• Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.

  Rowles BM, Findling RL. Rowles BM, et al. Dev Disabil Res Rev. 2010;16(3):273-82. doi: 10.1002/ddrr.120. Dev Disabil Res Rev. 2010. PMID: 20981766 Review.
• [The practice and problem of therapeutic agents for AD/HD].

  Tanaka H, Miyajima T. Tanaka H, et al. No To Hattatsu. 2010 May;42(3):213-6. No To Hattatsu. 2010. PMID: 23858580 Review. Japanese. No abstract available.
• Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder.

  Stiefel G, Besag FM. Stiefel G, et al. Drug Saf. 2010 Oct 1;33(10):821-42. doi: 10.2165/11536380-000000000-00000. Drug Saf. 2010. PMID: 20812768 Review.
• Pharmacological management of attention-deficit hyperactivity disorder.

  Reeves G, Schweitzer J. Reeves G, et al. Expert Opin Pharmacother. 2004 Jun;5(6):1313-20. doi: 10.1517/14656566.5.6.1313. Expert Opin Pharmacother. 2004. PMID: 15163276 Review.